SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-001460
Filing Date
2021-01-11
Accepted
2021-01-11 16:33:01
Documents
2
Period of Report
2021-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea133114-8k_aikidopharma.htm 8-K 32077
2 CERTIFICATE OF DESIGNATION OF SERIES M PREFERRED STOCK ea133114ex3-1_aikidopharma.htm EX-3.1 102737
  Complete submission text file 0001213900-21-001460.txt   136371
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
AIkido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 21521184
SIC: 8731 Services-Commercial Physical & Biological Research